文献速递主动脉疾病静脉血栓栓塞

破裂性腹主动脉瘤的EVAR优先策略:聚焦Fitzgerald分型与静脉血栓

Endovascular Aneurysm Repair-First Strategy for Ruptured Aneurysm Focuses on Fitzgerald Classification and Vein Thrombosis.
PubMed 文献 · Ann Vasc Surg · 2018-05-18

2011至2017年,31例破裂性腹主动脉瘤患者在本院接受EVAR优先策略,按Fitzgerald分型分为F-1组(A组,n=9)与F-2至F-4伴明显腹膜后血肿组(B组,n=22)。B组30天死亡率为23.8%,A组为0%;B组发生6例血肿相关并发症,包括4例深静脉血栓。A组3年生存率显著高于B组(100% vs 52.3%,P=0.016),但免于主动脉死亡率的差异未达统计学显著(100% vs 66.7%,P=0.056)。

要点

  • B组22例中16例(73%)术前休克,30天死亡率为23.8%,A组为0%。
  • B组发生6例血肿相关并发症:深静脉血栓4例、腹腔间隔室综合征1例、血肿感染1例。
  • A组3年生存率显著高于B组(100% vs 52.3%,P=0.016),免于主动脉死亡率无显著差异(P=0.056)。

核心结论

  • 作者认为使用EVAR治疗破裂性腹主动脉瘤是有效策略,应特别关注与腹膜后血肿相关的并发症,尤其是静脉血栓。

研究设计与样本

  • 单中心研究,2011年至2017年在本院因破裂性腹主动脉瘤接受EVAR的31例患者,按Fitzgerald分型分为A组(F-1,n=9)与B组(F-2至F-4伴明显腹膜后血肿,n=22)进行比较。

主要发现

  • A组与B组基线特征相似;B组中F-2为8例、F-3为10例、F-4为4例,22例中16例(73%)术前休克。
  • 手术时间A组147 min vs B组131 min,差异无统计学意义(P=0.48)。
  • 30天死亡率A组0% vs B组23.8%,B组死亡病例中F-4为2例、F-3为3例。
  • B组发生6例血肿相关并发症:深静脉血栓4例、腹腔间隔室综合征1例、血肿感染1例;其中1例深静脉血栓发生肺栓塞导致心脏骤停。
  • 3年生存率A组100% vs B组52.3%(P=0.016);免于主动脉死亡率A组100% vs B组66.7%,差异未达统计学显著(P=0.056)。

临床怎么用

  • 作者认为对破裂性腹主动脉瘤采用EVAR优先策略是有效策略,应特别关注与腹膜后血肿相关的并发症,尤其是静脉血栓。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recent study have demonstrated the good results of endovascular aneurysm repair (EVAR) for ruptured abdominal aortic aneurysms (RAAAs). We report on the results of our EVAR-first strategy for RAAAs focuses on Fitzgerald (F) classification and vein thrombosis. MATERIALS AND METHODS: From 2011 to 2017, 31 patients with RAAA underwent EVAR at our hospital. We compared F-1 patients (group A) with F-2 to F-4 patients with obvious retroperitoneal hematoma (group B). RESULTS: The baseline characteristics in group A (n = 9) and group B (n = 22) were similar. In group B, there were 8 cases of F-2, 10 cases of F-3, and 4 cases of F-4. Of the 22 cases in group B, 16 (73%) cases involved preoperative shock. Operation time was not significantly different (group A: 147 min and group B: 131 min, P = 0.48). The total mortality rate of group A and group B combined was 77.4%. The 30-day mortality was 0% for group A and 23.8% for group B, in which there were 2 F-4 cases and 3 F-3 cases. In group B, hematoma-related complications developed in 6 cases (deep vein thrombosis: 4 cases, abdominal compartment syndrome: 1 case, and hematoma infection: 1 case), and 1 case with deep vein thrombosis developed a pulmonary embolism that resulted in cardiac arrest. The 3-year survival rate was significantly higher for group A (100% vs. 52.3%, P = 0.016), but the freedom from aortic death rate was not significantly different (100% vs. 66.7%, P = 0.056). CONCLUSIONS: Using EVAR for RAAA is a valid strategy. Certain complications that are associated with peritoneal hematoma, especially venous thrombosis, should receive particular attention.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Murakami Y, Toya N, Fukushima S, et al. Endovascular Aneurysm Repair-First Strategy for Ruptured Aneurysm Focuses on Fitzgerald Classification and Vein Thrombosis. Ann Vasc Surg. 2018. PMID: 29778613. doi:10.1016/j.avsg.2018.03.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。